Lacerda, Jessica Zani; Drewes, Carine Cristiane; Mimura, Kallyne Kioko Oliveira; Zanon, Caroline de Freitas; Ansari, Tahera; Gil, Cristiane Damas; Greco, Karin Vicente; Farsky, Sandra Helena Poliselli 
; Oliani, Sonia Maria
Source: Frontiers in Pharmacology. Unidade: FCF
Subjects: CITOCINAS, FIBROBLASTOS, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACERDA, Jessica Zani et al. Annexin A1(2-26) treatment improves skin heterologous transplantation by modulating inflammation and angiogenesis processes. Frontiers in Pharmacology, v. 9, p. 1-11 art. 1015, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.01015. Acesso em: 04 out. 2024.APA
Lacerda, J. Z., Drewes, C. C., Mimura, K. K. O., Zanon, C. de F., Ansari, T., Gil, C. D., et al. (2018). Annexin A1(2-26) treatment improves skin heterologous transplantation by modulating inflammation and angiogenesis processes. Frontiers in Pharmacology, 9, 1-11 art. 1015. doi:10.3389/fphar.2018.01015NLM
Lacerda JZ, Drewes CC, Mimura KKO, Zanon C de F, Ansari T, Gil CD, Greco KV, Farsky SHP, Oliani SM. Annexin A1(2-26) treatment improves skin heterologous transplantation by modulating inflammation and angiogenesis processes [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-11 art. 1015.[citado 2024 out. 04 ] Available from: https://doi.org/10.3389/fphar.2018.01015Vancouver
Lacerda JZ, Drewes CC, Mimura KKO, Zanon C de F, Ansari T, Gil CD, Greco KV, Farsky SHP, Oliani SM. Annexin A1(2-26) treatment improves skin heterologous transplantation by modulating inflammation and angiogenesis processes [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-11 art. 1015.[citado 2024 out. 04 ] Available from: https://doi.org/10.3389/fphar.2018.01015
